A recall of a common ADHD medication, a generic version of Vyvanse, has been issued by the FDA. The affected medicine is specifically called lisdexamfetamine dimesylate capsules, manufactured by Sun Pharmaceutical Industries in New Jersey. The reason for the Class II recall comes from failed dissolution tests for the capsules, which means that it doesn’t dissolve as expected and could reduce its effectiveness. Vyvanse is a very common stimulant medication with over 9 million prescriptions of the drug dispensed in 2023 in the United States, according to ClinCalc.
Recall list of Lisdexamfetamine Dimesylate lot numbers
The following are the lot numbers for the recalled Lisdexamfetamine Dimestylate drugs, which have been packaged in various capsule sizes in 100-count bottles. The expiration dates for each medication has been listed as well.
- Lisdexamfetamine Dimesylate Capsules, 10 mg (100-count)
- AD42468 – Exp. Date: 2/28/2026
- AD48705 – Exp. Date: 4/30/2026
- Lisdexamfetamine Dimesylate Capsules, 20 mg (100-count)
- AD42469 – Exp. Date: 2/28/2026
- AD48707 – Exp. Date: 4/30/2026
- Lisdexamfetamine Dimesylate Capsules, 30 mg (100-count)
- AD42470 – Exp. Date: 2/28/2026
- AD48708 – Exp. Date: 4/30/2026
- Lisdexamfetamine Dimesylate Capsules, 40 mg (100-count)
- AD48709 – Exp. Date: 4/30/2026
- AD50894 – Exp. Date: 5/31/2026
- Lisdexamfetamine Dimesylate Capsules, 50 mg (100-count)
- AD48710 – Exp. Date: 4/30/2026
- AD50895 – Exp. Date: 5/31/2026
- Lisdexamfetamine Dimesylate Capsules, 60 mg (100-count)
- AD48711 – Exp. Date: 4/30/2026
- AD50896 – Exp. Date: 5/31/2026
- Lisdexamfetamine Dimesylate Capsules, 70 mg (100-count)
- AD48712 – Exp. Date: 4/30/2026
- AD50898 – Exp. Date: 5/31/2026
A Class II recall, as defined by the FDA, is for item that “may cause temporary or medically reversible adverse health consequences.”
No press release was issued concerning the recall by Sun Pharmaceutical Industries, so there are no provided instructions on what consumers should do if they have affected medication in this case. Still, it is recommended that consumers contact their prescribing doctor or pharmacy regarding a possible refund or a refill for their prescription.
Last week, two other medications were recalled, one for high blood pressure and another for cholesterol.
